Abbisko Cayman Revenue

In the year 2025, Abbisko Cayman had annual revenue of 612.12M CNY with 21.45% growth.

Revenue

612.12M CNY

Revenue Growth

+21.45%

P/S Ratio

11.72

Revenue / Employee

2.71M CNY

Employees

226

Market Cap

7.98B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	612.12M	108.13M	21.45%
Dec 31, 2024	503.99M	484.93M	2,544.24%
Dec 31, 2023	19.06M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	22.68M	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Lepu Biopharma	767.54M
Alphamab Oncology	861.24M
CK Life Sciences Int'l., (Holdings)	5.49B
CStone Pharmaceuticals	221.89M
Shanghai Haohai Biological Technology	2.75B
HBM Holdings	908.35M
CARsgen Therapeutics Holdings	139.84M
Ocumension Therapeutics	595.79M

Revenue Rankings